AzTrials
AzTrials

Treatment RefusalBEASTNCT04098588

Behavioral Economics Intervention to Increase Treatment Seeking in the National Guard

A study testing BEAST and Descriptive Feedback in people with Treatment Refusal, run by University of Southern Mississippi at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study is a randomized controlled trial of a single-session behavioral economics (research combining the areas of economics, social psychology, and cognitive psychology) intervention (i.e., BEAST) is a"warrior-culture" consistent (i.e., focusing on positive soldier traits, solving practical problems), highly… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Treatment Refusal
What is being tested?
BEAST and Descriptive Feedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteUnited States
Study dates
15 Dec 2019to 29 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • National Guard active
  • > 17 ACSS-FAD

Who cannot join

  • those determined by military or study personnel to be actively psychotic, manic, or who are imminently suicidal and in need of emergency services.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Southern Mississippi

    Hattiesburg, Mississippi, 39406-0002

Other trials in United States

About this study

The study is a randomized controlled trial of a single-session behavioral economics (research combining the areas of economics, social psychology, and cognitive psychology) intervention (i.e., BEAST) is a"warrior-culture" consistent (i.e., focusing on positive soldier traits, solving practical problems), highly scalable, and extremely brief (10-minute) intervention to encourage treatment seeking among MS National Guard problems for various life stressors. Participants will be 112 National Guard members. It is hypothesized that BEAST will lead to more self-reported motivation to seek treatment and more actual treatment seeking behavior.

Being tested
BEAST, Descriptive Feedback
Medical subject headings
Treatment Refusal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BEASTBehavioural

    See Arm Description

  • Descriptive FeedbackBehavioural

    See Arm Description

Study groups in NCT04098588
Study groupRoleWhat they receive
BEASTExperimentalThere are 3 parts to BEAST. Part 1 involves the Behavioral Nudge technique using previously collected injunctive and descriptive norms from a National Guard sample. Soldiers will be given a customized feedback form that shows norms relevant to the target behavior they selected. The soldier will be given a chance to ask any follow-up questions. Part 2 of the intervention focuses on the principle of targeting others, considering how a change would impact those closest to them. Part 3 will utilize the Reciprocal Concessions procedure combined with the Reducing Barriers technique.
Receives: Behavioral: BEAST
Descriptive FeedbackActive comparatorThis condition will involve a presentation of descriptive data based on the soldiers' tests scores and an opportunity to ask any follow-up questions. This process is a component of some behavioral change interventions (e.g., motivational interviewing); therefore this should be a more useful control condition (mirroring parts 1 and 2 of the active condition) versus a more passive or waitlist control condition. Participants in the control condition will also be given standard referral information to the USM Psychology Clinic (mirroring part 3 of the active condition).
Receives: Behavioral: Descriptive Feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychosocial Treatments Interview-Revised

    Measure changes in treatment seeking behavior

    Measured: 1 month post intervention

  2. University of Rhode Island Change Assessment

    Measure motivation to change the target behavior

    Measured: 1 month post intervention

Secondary outcomes (2)
  1. Psychosocial Treatments Interview-Revised

    Measure changes in treatment seeking behavior

    Measured: 3 month post intervention

  2. University of Rhode Island Change Assessment

    Measure motivation to change the target behavior

    Measured: 3 month post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2019
  2. Study start15 Dec 2019
  3. Primary completion29 Mar 2023 (estimated)
  4. Study completion29 Mar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04098588
Sponsor's protocol ID
W81XWH-16-2-0003
Acronym
BEAST
Status last verified
Oct 2022
First submitted
18 Sep 2019
Last updated
4 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: After the study is completed will discuss with Department of Defense /Military Suicide Research Consortium on ability to share IPD.

Publications

  • Capron DW, Karnick AT, Buerke M, Bauer BW, Anestis MD. Recruiting National Guard Members for Online Suicide Prevention Research: Engagement, Eligibility, and Ethical Considerations Across Mental Health and Fearlessness-About-Death Study Labels. Mil Med. 2026 Sep 24:usag435. doi: 10.1093/milmed/usag435. Online ahead of print.

    PubMed 42784716

Questions about this trial

What is this clinical trial studying?

A study testing BEAST and Descriptive Feedback in people with Treatment Refusal, run by University of Southern Mississippi at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychosocial Treatments Interview-Revised (time frame: 1 month post intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04098588, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in